BioTheryX Announces Appointments of Three New Members to its Board of Directors
SAN DIEGO, Aug. 6, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on creating life-saving medicines through targeted [...]
BioTheryX Announces First Patient Dosed with BTX-A51 in Phase 1 Clinical Trial in Patients with Advanced Solid Tumors
SAN DIEGO, June 9, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving [...]
BioTheryX to Present at the 2021 Jefferies Virtual Healthcare Conference
SAN DIEGO, May 25, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving [...]
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
First molecular glue program, BTX-1188, expected to enter the clinic by the end of 2021 Additional protein degradation programs [...]
BioTheryX Announces Expansion of Scientific Advisory Board with Appointment of Brenda Schulman
SAN DIEGO, May 18, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving [...]
BioTheryX to Present at 2021 RBC Capital Markets Global Healthcare Conference
SAN DIEGO, May 4, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving [...]
BioTheryX Announces Expansion of Scientific Advisory Board
SAN DIEGO, April 7, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving [...]
BioTheryX to Present at the Barclays Global Healthcare Conference and the Credit Suisse Solebury Trout Healthcare Innovators Conference
SAN DIEGO, March 3, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving [...]
BioTheryX to Participate in Upcoming Scientific and Investor Events
SAN DIEGO, Feb. 15, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving medicines, [...]
BioTheryX Appoints Jamie Donadio as Chief Financial Officer
SAN DIEGO, Jan. 7, 2021 /PRNewswire/ -- BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving [...]